Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2008 2
2009 1
2010 3
2011 4
2013 1
2014 3
2015 1
2016 3
2017 3
2018 2
2019 3
2020 4
2021 3
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

39 results
Results by year
Filters applied: . Clear all
Page 1
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
von Minckwitz G, Procter M, de Azambuja E, Zardavas D, Benyunes M, Viale G, Suter T, Arahmani A, Rouchet N, Clark E, Knott A, Lang I, Levy C, Yardley DA, Bines J, Gelber RD, Piccart M, Baselga J; APHINITY Steering Committee and Investigators. von Minckwitz G, et al. N Engl J Med. 2017 Jul 13;377(2):122-131. doi: 10.1056/NEJMoa1703643. Epub 2017 Jun 5. N Engl J Med. 2017. PMID: 28581356 Free PMC article. Clinical Trial.
Role of ctDNA in Breast Cancer.
Sant M, Bernat-Peguera A, Felip E, Margelí M. Sant M, et al. Among authors: margeli m. Cancers (Basel). 2022 Jan 9;14(2):310. doi: 10.3390/cancers14020310. Cancers (Basel). 2022. PMID: 35053474 Free PMC article. Review.
Current perspectives of treatment of ductal carcinoma in situ.
Estévez LG, Alvarez I, Seguí MÁ, Muñoz M, Margelí M, Miró C, Rubio C, Lluch A, Tusquets I. Estévez LG, et al. Among authors: margeli m. Cancer Treat Rev. 2010 Nov;36(7):507-17. doi: 10.1016/j.ctrv.2010.03.007. Epub 2010 May 11. Cancer Treat Rev. 2010. PMID: 20462701 Review.
Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy.
Castellví M, Felip E, Ezeonwumelu IJ, Badia R, Garcia-Vidal E, Pujantell M, Gutiérrez-Chamorro L, Teruel I, Martínez-Cardús A, Clotet B, Riveira-Muñoz E, Margelí M, Ballana E. Castellví M, et al. Among authors: margeli m. Cancers (Basel). 2020 Mar 18;12(3):713. doi: 10.3390/cancers12030713. Cancers (Basel). 2020. PMID: 32197329 Free PMC article.
Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis.
Hartkopf AD, Brucker SY, Taran FA, Harbeck N, von Au A, Naume B, Pierga JY, Hoffmann O, Beckmann MW, Rydén L, Fehm T, Aft R, Solà M, Walter V, Rack B, Schuetz F, Borgen E, Ta MH, Bittner AK, Fasching PA, Fernö M, Krawczyk N, Weilbaecher K, Margelí M, Hahn M, Jueckstock J, Domschke C, Bidard FC, Kasimir-Bauer S, Schoenfisch B, Kurt AG, Wallwiener M, Gebauer G, Klein CA, Wallwiener D, Janni W, Pantel K. Hartkopf AD, et al. Among authors: margeli m. Eur J Cancer. 2021 Sep;154:128-137. doi: 10.1016/j.ejca.2021.06.028. Epub 2021 Jul 12. Eur J Cancer. 2021. PMID: 34265505
Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive metastatic breast cancer: Patient-reported outcomes in the PEARL study.
Kahan Z, Gil-Gil M, Ruiz-Borrego M, Carrasco E, Ciruelos E, Muñoz M, Bermejo B, Margeli M, Antón A, Casas M, Csöszi T, Murillo L, Morales S, Calvo L, Lang I, Alba E, de la Haba-Rodriguez J, Ramos M, López IÁ, Gal-Yam E, Garcia-Palomo A, Alvarez E, González-Santiago S, Rodríguez CA, Servitja S, Corsaro M, Rodrigálvarez G, Zielinski C, Martín M. Kahan Z, et al. Among authors: margeli m. Eur J Cancer. 2021 Oct;156:70-82. doi: 10.1016/j.ejca.2021.07.004. Epub 2021 Aug 20. Eur J Cancer. 2021. PMID: 34425406 Free article. Clinical Trial.
New Drugs, Old Toxicities: Pneumonitis Related to Palbociclib - A Case Report.
Felip E, Llobera L, Perez-Mañá C, Quintela D, Guasch I, Margelí M, Teruel I, Cirauqui B, Centeno C, Romeo M, Ballana E, Quiroga V. Felip E, et al. Among authors: margeli m. Breast Care (Basel). 2020 Oct;15(5):548-552. doi: 10.1159/000504618. Epub 2019 Dec 18. Breast Care (Basel). 2020. PMID: 33224001 Free PMC article.
39 results